Lead author Abigail Fabiano and colleagues used a shear-stress protocol designed to mimic the physical stresses circulating tumor cells experience in vivo. They began with two prostate cancer models: LNCaP cells, representing earlier-stage disease and sensitive to androgen deprivation, and PC3 cells, representing advanced, androgen-resistant cancer. Under cyclic high-shear exposure, the researchers repeatedly selected survivors and expanded them through multiple training rounds over roughly six months.

After training, most cells from both lines became mechanoresistant, meaning they could withstand periodic bursts of force that previously triggered widespread damage. Importantly, the resistant and non-resistant populations often appeared similar under standard observation, suggesting that resistance is encoded more subtly in cellular programs than in overt phenotype.

To uncover the underlying cause, the team sequenced genomes from the mechanoresistant populations. Despite comparable appearances, both resistant groups showed increased expression of a gene called CALB2. The researchers further observed that CALB2 is elevated in cancer cells obtained from metastatic prostate cancer patients, indicating that the adaptation observed in the lab may reflect an existing pathway in human disease.

To test whether CALB2 was causal, the researchers used gene editing to reduce CALB2 expression in mechanoresistant cells and then re-ran the shear-stress challenge. Cells with diminished CALB2 once again showed vulnerability and failed during the stress pulses, while cells retaining high CALB2 expression continued to survive. This cause-and-effect result positions CALB2 as a key contributor to mechanoresistance.

The study argues that mechanoresistance models can reveal previously overlooked metastasis predictors. King’s group emphasizes that distant spread in prostate cancer remains difficult to treat and is associated with poor prognosis, so new mechanical risk factors and drug targets could improve how clinicians anticipate and counter metastatic capability.

By combining mechanical selection, whole-genome profiling, and targeted gene perturbation, the research establishes a framework for identifying metastasis-relevant vulnerabilities tied to a cell’s ability to endure circulation. The findings also suggest that additional genetic drivers—beyond CALB2—likely contribute to the full resistance phenotype, and these are now under investigation in the lab.

Finally, the work was supported by major research funding from the National Institutes of Health, the Cancer Prevention and Research Institute of Texas, and a National Science Foundation Graduate Research Fellowship, underscoring the broader push to connect physical microenvironments to cancer evolution.

Subject of Research: Cells
Article Title: CALB2 is a Mechanoresistance Gene in Metastatic Prostate Cancer
News Publication Date: 20-Jul-2026
Web References: http://dx.doi.org/10.1002/advs.76535
References: 10.1002/advs.76535
Image Credits:
Keywords: Prostate cancer; Cancer; Metastasis

The actin cytoskeleton is a fundamental cellular scaffold responsible for maintaining cell shape, enabling motility, and facilitating intracellular transport. Its dynamic remodeling is especially crucial in pathological contexts, such as cancer progression and metastasis, where enhanced cell migration allows malignant cells to invade surrounding tissues and establish secondary tumors. It is well-known that ROS, a group of highly reactive molecules derived from oxygen metabolism, act as intracellular signaling mediators influencing various cellular processes, including cytoskeletal rearrangements.

Previous studies have demonstrated that Transient Receptor Potential Melastatin 2 (TRPM2) channels, a type of calcium-permeable ion channel, can be activated by oxidative stress stimuli like hydrogen peroxide (H₂O₂), leading to altered intracellular ion dynamics. However, prior to this current investigation, the exact mechanisms by which TRPM2 channels influence actin remodeling in the context of pathophysiologically relevant ROS generation remained largely unexplored, particularly in prostate cancer cells.

The research team focused on two widely used prostate cancer cell lines, PC-3 and DU145, to emulate the tumor environment and investigate how endogenously produced ROS affect actin filament organization and cell migration. Through a combination of molecular probes and advanced imaging techniques, they intricately mapped the cellular responses to ROS and dissected the role of TRPM2 channels in this process.

Specifically, the study employed phalloidin staining and expression of pActin-tdTomato constructs to visualize actin structures at high resolution with confocal microscopy. This approach allowed for precise delineation of cytoskeletal changes triggered by ROS in live cells. To monitor intracellular metal ion dynamics, the team used Fluozin3-AM and Fluo4-AM probes to detect fluctuations in zinc (Zn²⁺) and calcium (Ca²⁺) concentrations, respectively—both ions playing critical regulatory roles in cytoskeletal modulation.

The results revealed a striking phenomenon: exposure to H₂O₂ and saturated fatty acid palmitate elicited significant TRPM2-dependent increases in cytosolic Ca²⁺ and Zn²⁺. These ion surges were directly implicated in promoting extensive actin remodeling, characterized by reorganization of actin filaments, which in turn facilitated enhanced migratory behavior in both PC-3 and DU145 cells.

Further validation came from experiments involving pharmacological inhibitors of TRPM2 channels and genetic knockdown techniques. When TRPM2 function was abrogated, the ROS-induced elevations in intracellular Ca²⁺ and Zn²⁺ were markedly suppressed. Consequently, actin remodeling responses and cell migration capabilities were significantly diminished, affirming the essential role of TRPM2 in translating ROS signals into cytoskeletal dynamics.

Moreover, the study highlighted the importance of Zn²⁺ homeostasis in this signaling axis. Chelation of Zn²⁺ ions via selective binding agents impaired the actin remodeling process, underscoring zinc as a critical secondary messenger downstream of TRPM2 activation. This novel insight challenges the traditionally calcium-centric view of ion-mediated cytoskeletal regulation, opening new avenues for understanding zinc’s contribution to cancer cell motility.

From a mechanistic perspective, the dual regulation of Ca²⁺ and Zn²⁺ by TRPM2 channels appears to orchestrate a finely tuned signaling cascade that ultimately remodels the actin network. This remodeling is essential for the cellular morphological changes and protrusive activities required for directed migration—key processes in metastatic dissemination of cancer cells.

The clinical implications of this discovery are profound. Targeting TRPM2 channels or modulating intracellular Zn²⁺ levels might serve as innovative therapeutic approaches to hinder cancer cell migration and metastasis. Given the aggressive nature of prostate cancer and its capacity for widespread dissemination, interventions that disrupt this newly uncovered signaling pathway could significantly impact patient outcomes and survival rates.

Future research stemming from this work will likely focus on delineating the precise molecular targets of Zn²⁺ within the cytoskeletal framework and identifying signaling intermediates modulated by TRPM2 activation. Understanding these downstream effectors will enhance our capacity to design specific drugs capable of blocking metastatic progression without compromising normal cellular functions.

Additionally, the potential cross-talk between TRPM2-mediated ion fluxes and other cellular signaling networks remains an exciting field for exploration. ROS-dependent pathways intersect multiple metabolic and transcriptional cascades, and unraveling these interactions could reveal broader systemic effects of TRPM2 regulation in cancer biology.

This study also raises interesting questions regarding the role of lipid-derived ROS, such as palmitate-induced oxidative stress, in cancer cell behavior. The apparent ability of fatty acids to activate TRPM2 channels and orchestrate cytoskeletal plasticity highlights the intricate relationship between metabolic alterations and cancer progression.

In summary, the elucidation of TRPM2 channels as crucial mediators linking oxidative stress to actin cytoskeleton remodeling and enhanced cell migration paints a comprehensive picture of a complex signaling axis operative in prostate cancer cells. The discovery accentuates the multifaceted role of ion channels in cancer biology and underscores the therapeutic promise of targeting these pathways.

As researchers continue to dissect the nuances of ROS signaling and TRPM2 function, the field moves closer to translating these fundamental insights into tangible clinical interventions. This paradigm shift towards ion channel-targeted therapies could redefine strategies aimed at combating metastatic prostate cancer and improve prognosis for countless patients.

The findings in this study represent a monumental step forward in our understanding of the interplay between oxidative stress, ion channel regulation, and cytoskeletal dynamics in cancer metastasis. They offer a compelling rationale for integrating molecular ion channel modulators into the armamentarium of cancer therapeutics, heralding a new era of precision medicine tailored to disrupt the metastatic cascade at its core.

Subject of Research: TRPM2 channel-mediated reactive oxygen species (ROS)-induced actin remodeling and cell migration mechanisms in prostate cancer cells

Article Title: TRPM2 channels mediate ROS-induced actin remodeling and cell migration of prostate cancer cells

Article References:
Qi, P., Zhao, J., Zhang, H. et al. TRPM2 channels mediate ROS-induced actin remodeling and cell migration of prostate cancer cells. BMC Cancer 25, 956 (2025). https://doi.org/10.1186/s12885-025-14333-3

Image Credits: Scienmag.com

DOI: https://doi.org/10.1186/s12885-025-14333-3